RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions by Estornes, Yann et al.
OPEN
RIPK1 promotes death receptor-independent
caspase-8-mediated apoptosis under unresolved
ER stress conditions
Y Estornes1,2, MA Aguileta1,2, C Dubuisson1,2, J De Keyser1,2, V Goossens1,2, K Kersse1,2,5, A Samali3,4, P Vandenabeele1,2
and MJM Bertrand*,1,2
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress and results in the activation of the
unfolded protein response (UPR), which aims at restoring ER homeostasis. However, when the stress is too severe the UPR
switches from being a pro-survival response to a pro-death one, and the molecular mechanisms underlying ER stress-mediated
death have remained incompletely understood. In this study, we identified receptor interacting protein kinase 1 (RIPK1)—a kinase
at the crossroad between life and death downstream of various receptors—as a new regulator of ER stress-induced death. We
found that Ripk1-deficient MEFs are protected from apoptosis induced by ER stressors, which is reflected by reduced caspase
activation and PARP processing. Interestingly, the pro-apoptotic role of Ripk1 is independent of its kinase activity, is not regulated
by its cIAP1/2-mediated ubiquitylation, and does not rely on the direct regulation of JNK or CHOP, two reportedly main players in
ER stress-induced death. Instead, we found that ER stress-induced apoptosis in these cells relies on death receptor-independent
activation of caspase-8, and identified Ripk1 upstream of caspase-8. However, in contrast to RIPK1-dependent apoptosis
downstream of TNFR1, we did not find Ripk1 associated with caspase-8 in a death-inducing complex upon unresolved ER stress.
Our data rather suggest that RIPK1 indirectly regulates caspase-8 activation, in part via interaction with the ER stress sensor
inositol-requiring protein 1 (IRE1).
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The endoplasmic reticulum (ER) is the main subcellular
compartment for protein folding and maturation, and an
essential organelle for calcium storage and lipid synthesis.
Numerous physiological (e.g., high demand of protein secre-
tion) and pathological (e.g., protein mutation) conditions can
alter the proper function of this organelle, leading to
accumulation of un- or misfolded proteins in the ER lumen
and inducing ER stress. Eukaryotic cells have developed an
adaptive molecular response, known as the unfolded protein
response (UPR), to sense and adapt to ER stress. In
mammalian cells, the UPR emerges from three ER-
anchored receptors: inositol-requiring protein 1 (IRE1), protein
kinase RNA-like ER kinase (PERK), and activating transcrip-
tion factor 6 (ATF6). These sensors restore ER homeostasis
by activating signaling pathways that increase the folding
capacity of the ER, reduce the global synthesis of new
proteins, and promote alternative forms of protein degrada-
tion. However, in conditions of too severe ER stress, the UPR
may fail to restore ER homeostasis and then turns into a toxic
signal inducing apoptosis.1–4
ER stress is associated with various human diseases
including cancer, neurodegenerative disorders, diabetes,
obesity, and inflammatory diseases.5,6 However, although
ER stress-induced death is now recognized as an important
factor for the development and progression of certain of these
diseases, the molecular mechanisms of its induction have
remained incompletely understood. Gaining a better under-
standing of the molecular mechanisms regulating survival and
death upon ER stress is therefore of great importance as it
may lead to the identification of new therapeutic targets for the
treatment of these diseases.
Previous studies have implicated the three branches of the
UPR in the death induced by unresolved ER stress, and
activation of the intrinsic mitochondrial apoptotic pathway—via
the regulation of the Bcl-2 family members—is reported as one
of the main mechanism for these sensors to promote
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apoptosis.2,3,7 Activated PERK and ATF6 have been shown to
induce expression of the transcription factor C/EBP-homo-
logous protein (CHOP, also called GADD153), which pro-
motes cell death by regulating the expression of a panel of
proteins belonging to the Bcl-2 family such as Bcl-2, Bim,
Puma, and Bax.3,7 Moreover, PERK-induced protein synth-
esis through ATF4- and CHOP-mediated transcription was
also reported to generate an ER oxidase 1α (ERO1α)-
dependent oxidative stress leading to IP3-induced calcium
release and death.8–10
IRE1 possesses, within its cytoplasmic tail, domains
conferring it kinase and endoribonuclease activities. Under
ER stress conditions, IRE1 trans-autophosphorylation and
oligomerization activates its RNase domain leading to the
specific splicing of the transcription factor X-box-binding
protein 1 (XBP-1). The spliced form of XBP-1 induces the
expression of numerous genes involved in ER homeostasis
and survival.1 However, under unresolved ER stress condi-
tions, IRE1 may trigger cell death by degrading ER-localized
mRNA encoding pro-survival proteins through a process
known as regulated IRE1-dependent decay (RIDD).11–14
Recently, RIDD has been reported to contribute to BID-
dependent activation of the mitochondrial apoptotic pathway
by degrading miRNA repressing expression and activation of
caspase-2.15,16 IRE1 is also suggested to promote intrinsic
apoptosis by activating c-Jun N-terminal kinase (JNK).
Indeed, IRE1 was shown to interact with tumor necrosis factor
receptor (TNFR)-associated factor 2 (TRAF2), allowing the
downstream activation of the apoptosis signal-regulated
kinase 1 (ASK1)/JNK pathway leading to apoptosis.17–20
Sustained JNK activation, as reported to occur during ER
stress, is known to trigger apoptosis by regulating the activity
of Bcl-2 family members.21,22 Interestingly, activation of JNK
by IRE1 was shown to depend on the receptor-interacting
serine/threonine protein kinase 1 (RIPK1) via TNF-
independent interaction of TNFR1 with IRE1 at the ER
membrane.23 Beside the regulation of the JNK pathway, the
IRE1–TRAF2 interaction has also been reported to promote
TNFR1-dependent apoptosis by mediating NF-κB-dependent
autocrine production of TNF.24
RIPK1 is a kinase at the crossroad of life and death, and has
a central role in the signaling pathways activated downstream
of several TNFR and Toll-like receptor (TLR) family
members.25–28 Downstream of TNFR1, RIPK1-dependent
cell fate decisions were shown to rely on cellular inhibitor of
apoptosis 1 and 2 (cIAP1/2)-dependent ubiquitylation of
RIPK1 at the receptor complex (complex I). The ubiquitin
chains conjugated to RIPK1 function as a platform for the
recruitment and activation of transforming growth factor-beta-
activated kinase 1 (TAK1) complex.29–32 Activated TAK1
subsequently activates the mitogen-activated protein kinase
(MAPK) and NF-κB pathways, which together drive the
transcription of pro-inflammatory and anti-apoptotic genes.
In conditions of cIAP1/2 depletion or TAK1 inhibition, RIPK1
dissociates from complex I and mediates, in a kinase-
dependent way, the formation of a cytosolic RIPK1/FADD/
caspase-8 death complex (complex IIb) that triggers
apoptosis.29,33–35 In condition of caspase inhibition, RIPK1
kinase activity can additionally drive a caspase-independent
regulated form of necrosis known as necroptosis.36
The fact that RIPK1 is reported to mediate IRE1/TNFR1-
dependent JNK activation suggests that RIPK1 could directly
contribute to activation of the intrinsic apoptotic machinery
resulting from unresolved ER stress.23 However, a role for
RIPK1 in ER stress-induced apoptosis has not been demon-
strated yet. In this study, we show that RIPK1 deficiency
protects the cells from ER stress-triggered apoptosis but,
surprisingly and in contradiction with previous studies, found
that this protection was not the result of a defect of JNK
activation or TNFR1 signaling. Instead, we found that RIPK1
promotes death receptor-independent caspase-8 activation,
which is required for the downstream activation of caspase-9
and -3 and the induction of cell death. Interestingly, we found
that RIPK1 interacts with IRE1, which may initiate part of the
apoptotic function of RIPK1.
Results
RIPK1 is required for ER stress-induced apoptosis.
RIPK1 has been previously linked to the UPR by regulating
IRE1/TNFR1-mediated JNK activation.23 To investigate the
role of RIPK1 in ER stress-mediated death, we compared the
effect of the well-established ER stress inducer tunicamycin
on Ripk1+/+ and Ripk1−/− MEFs. Ripk1-deficient cells
exhibited a strong delay in death induced by tunicamycin
when compared with wild-type (WT) counterparts, resulting in
an ~50% protection after 24 h of treatment (Figure 1a). When
treated for a longer period of time, Ripk1+/+ MEFs reached
100% cell death much earlier than Ripk1−/− MEFs, indicating
that the delay in the death observed during the first 24 h was
maintained over time (Supplementary Figure S1a). Moreover,
cell death induction by two other ER stress inducers,
thapsigargin and brefeldin A, was also strongly reduced in
Ripk1-deficient cells compared with the WT counterpart
(Supplementary Figure S1b and c). These results indicate
that Ripk1 deficiency confers a general protection against ER
stress-mediated death.
In correlation with the death profiles, caspase-3-like activity
was reduced in Ripk1−/− compared with Ripk1+/+ cells
(Figure 1b), and Ripk1 deficiency led to a great reduction in
tunicamycin-induced caspase-3 and PARP processing
(Figure 1c), indicating that Ripk1mediates apoptosis triggered
by ER stress. Accordingly, caspase processing was also
reduced in Ripk1− /− cells stimulated with thapsigargin
(Supplementary Figure S1d). This defect in cell death
induction was not the result of an intrinsic defect of the cells,
since Ripk1−/− cells were sensitized to TNF-induced death
(Supplementary Figure S2), as previously described.37
To further demonstrate the role of RIPK1 in ER stress-
induced apoptosis, we stably reconstituted Ripk1−/− cells with
WT Ripk1, or with an empty control vector, using a doxycyclin-
inducible system. Doxycycline treatment of reconstituted
Ripk1−/− cells led to a level of Ripk1 expression comparable
to the endogenous one (Figure 1d). In addition, in the absence
of doxycycline, tunicamycin-induced caspase-3 activation
(monitored by PARP processing) was similar in cell recon-
stituted with Ripk1 or with the control vector (Figure 1e). By
contrast, the doxycycline-induced re-expression of Ripk1
greatly enhanced PARP processing upon tunicamycin
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treatment (Figure 1f), confirming a role for Ripk1 in ER stress-
mediated apoptosis.
To investigate whether the pro-apoptotic role of RIPK1
during ER stress requires its enzymatic activity, we tested
the effect of necrostatin-1 (Nec1), an inhibitor of RIPK1
kinase activity.38 We found that Nec1 had no effect on
tunicamycin-induced death or caspase-3 processing
(Figures 1g and h). Of note, blockade of caspases with the
broad-spectrum caspase inhibitor Z-VAD only partly protected
the cells from tunicamycin-mediated death (Figure 1g),
indicating that caspase-independent death also occurs
following ER stress, and/or that caspase inhibition induces a
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Figure 1 RIPK1 mediates ER stress-triggered apoptosis independently of its kinase activity. (a and b) Ripk1+/+ and Ripk1−/− MEFs were stimulated with 1 μg/ml
tunicamycin (Tu), and the percentage of cell death (a) or caspase-3 like activity (b) was measured in function of time using the Fluostar Omega fluorescence plate reader.
*Po0.01; error bars represent S.E.M. of six (a) and three (b) independent experiments. (c) Ripk1+/+ and Ripk1−/− MEFs were incubated with 1 μg/ml Tu for the indicated time,
and cell lysates were immunoblotted as indicated. (d–f) Ripk1−/−MEFs reconstituted with a doxycycline-inducible Ripk1 coding vector or with an empty vector (Ctrl) were treated
(+) or not (− ) with doxycycline (Dox) and then exposed (+) or not (− ) to 1 μg/ml Tu. The cells were then lysed and immunoblotted as indicated. (g) Ripk1+/+ MEFs were
incubated for 30 min with necrostatin-1 (Nec1) in the presence or absence of Z-VAD-fmk (Z-VAD), and then stimulated with 1 μg/ml Tu. The percentage of cell death was
measured as in (a). Error bars represent S.E.M. of three independent experiments. (h) Ripk1+/+ MEFs were incubated for 30 min with Nec1 and then stimulated with 1 μg/ml Tu
for the indicated time, and the cell lysates were immunoblotted as indicated
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switch to a non-apoptotic cell death modality—possibly
necroptosis. Nevertheless, combining Nec1 with Z-VAD did
not enhance the protection given by Z-VAD alone, implying
that the remaining death is not Ripk1 kinase-dependent
necroptosis.
cIAP1/2 are direct ubiquitin ligases for RIPK1, and cIAP1/2
depletion has been reported to sensitize cells to RIPK1-
dependent apoptosis downstream of TNFRs.28,29,34,35,39 In
addition, it has been shown that upregulation of cIAP1/2 in
response to ER stress has a survival role.40–43 However,
stimulation of the cells with the Smac mimetic BV6,
a compound that induces proteasomal degradation of
cIAP1/2,44 did not sensitize the cells to tunicamycin-induced
caspase-3 processing or cell death (Supplementary
Figure S3a and b). Of note, tunicamycin treatment did not
induce notable increase of cIAP1 expression in Ripk1+/+
MEFs (Supplementary Figure S3c).
Taken together, these results demonstrate that RIPK1
mediates ER stress-induced apoptosis independently of its
kinase activity, and that cIAP1/2 are not involved in this process.
The pro-apoptotic function of RIPK1 is independent of
JNK or CHOP regulation. RIPK1 has been reported to
mediate JNK activation during ER stress.23 Knowing the
implication of the JNK pathway in ER stress-induced
apoptosis,3,18,20,22 we logically hypothesized that the protec-
tion of the Ripk1−/− cells to tunicamycin-induced apoptosis
was a result of defective JNK activation. To test this
hypothesis, we first analyzed the role of the JNK pathway in
our cellular system by using the JNK inhibitor SP600125.
This inhibitor was functional as it completely blocked the
phosphorylation of c-Jun—a well-known substrate of JNK45
—following stimulation with TNF or IL-1β (Supplementary
Figure S4). Pretreatment of Ripk1+/+ cells with SP600125
decreased, in a dose-dependent manner, the processing of
caspase-3 and PARP triggered by tunicamycin (Figure 2a).
However, and unexpectedly, Ripk1 deficiency did not alter
activation of JNK—monitored by the phosphorylation of c-Jun
—in cells stimulated with tunicamycin (Figure 2b). Hence,
even though we confirmed the link between JNK activation
and ER stress-induced apoptosis,2,3 our results argue
against a role of RIPK1 in JNK activation. Our data therefore
indicate that the pro-apoptotic function of RIPK1 relies on the
activation of another pro-death pathway.
Several in vitro and in vivo studies have highlighted the
importance of CHOP for apoptosis induction during ER
stress.2,3 We therefore compared the induction of CHOP in
Ripk1+/+versus Ripk1−/− cells. RT-qPCR and immunoblot
analysis revealed that neither the mRNA nor the protein levels
of CHOP were affected by Ripk1 deficiency in response to
tunicamycin or thapsigargin treatment (Figures 2c and d;
Supplementary Figure S5), indicating that the pro-apoptotic
role of Ripk1 is independent of CHOP regulation. In addition,
Ripk1 deficiency did not alter the IRE1-dependent, spliced
XBP-1-mediated survival pathway, since the kinetics of Xbp-1
mRNA splicing and translation between Ripk1-deficient and
-proficient cells were identical (Supplementary Figure S6).
Taken together, these data demonstrate that the pro-
apoptotic function of RIPK1 does not involve JNK activation,
CHOP induction, or inhibition of XBP-1 splicing.
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Figure 2 RIPK1 does not regulate JNK or CHOP during ER stress. (a) Ripk1+/+MEFswere incubated for 30 min with 10 or 20 μM JNK inhibitor SP 600125 and then exposed
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RIPK1 acts upstream of caspase-8 activation during
unresolved ER stress. ER stress is widely reported to kill by
activating the intrinsic apoptotic pathway,3 and caspase-2 has
been suggested to act as the initiator caspase activating the
mitochondrial pathway.46,47 The analysis of our cell lysates
did not allow us to detect caspase-2 processing (data not
shown). Instead, on top of caspase-9 and -3 cleavage, we
detected clear evidence of caspase-8 processing, an initiator
caspase typically activated by death receptors in the extrinsic
apoptotic pathway (Figure 3a). Importantly, as previously
observed for caspase-3 and PARP, the cleavage of both
caspase-8 and caspase-9 was strongly decreased in the
absence of Ripk1, therefore placing Ripk1 upstream of these
caspases in the death pathway (Figure 3a). Of note,
knockdown of caspase-8 by stable shRNA transfection
prevented caspase-9, -3 and PARP processing, revealing a
role of caspase-8 upstream of the apoptosome (Figure 3b). In
agreement, caspase-8-deficient JA3 Jurkat cells were
protected against tunicamycin- and thapsigargin-induced
caspase-3 processing and death (Supplementary Figure S7).
Finally, in line with the hypothesis that RIPK1 and caspase-8
act in the same apoptotic pathway, the double invalidation
of Ripk1 and caspase-8 in MEFs did not further improve
the protection given by caspase-8 repression alone
(Figure 3c). These results therefore reveal that RIPK1-
dependent caspase-8 processing is crucial for ER
stress-mediated apoptosis, and suggest that caspase-8 is
the primarily initiator caspase activated under ER stress
conditions.
To further investigate the role of RIPK1 in the control of
caspase-8 activation, we examined whether Ripk1 and
caspase-8 interacted in response to ER stress in MEFs. As
previously reported,33 an interaction between caspase-8 and
RIPK1 was detected when the cells were stimulated with TNF
in the presence of TAK1 inhibitor (Figure 3d), validating the
efficiency of our caspase-8 immunoprecipitations. However,
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Figure 3 Ripk1 acts upstream of caspase-8 during ER stress-mediated death. (a) Ripk1+/+ and Ripk1−/− MEFs were exposed to 1 μg/ml tunicamycin (Tu) for the indicated
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we did not detect the presence of Ripk1 in caspase-8
immunoprecipitates when the cells were treated with tunica-
mycin (Figure 3d). These results therefore suggest that the
formation of an RIPK1-caspase-8 containing death complex in
response to ER stress is unlikely and that RIPK1 indirectly
regulates caspase-8 activation.
Caspase-8 activation occurs independently of the classi-
cal death receptor signaling. We next investigated the
possibility that caspase-8 activation could still occur through
the engagement of death receptors of the TNFR superfamily
by autocrine production of their respective ligands, as
previously suggested.24,48 We found that the processing of
caspase-8 and -3 induced by tunicamycin was not prevented
by the use of blocking antibodies targeting TNF or TRAIL, or
by a recombinant mouse Fas:Fc chimera, although
these approaches efficiently blocked activation of the
caspases when the agonists were provided exogenously
(Figures 4a–f). Because ligand-independent TNFR1 as well
as death receptor 5 (DR5) signaling have been reported
during ER stress conditions,23,49 we additionally tested the
effect of TNFR1, FAS, and DR5 depletion by siRNA. As
shown in Figure 5, neither Tnfr1, Fas, nor Dr5 repression had
any impact on tunicamycin-induced caspase-8 or -3 proces-
sing (Figures 5a, c, and e) or cell death (Figure 5i) although
the respective knockdown of these death receptors comple-
tely blocked caspases processing triggered by exogenous
agonists (Figures 5b, d, and f). Accordingly, knockdown of the
death receptor adaptor FADD had no effect on tunicamycin-
induced caspases activation or cell death (Figures 5g–i).
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silencing siRNA (siNS) or or with siRNA targeting Tnfr1 (siTnfr1), Fas (siFas), Dr5 (siDr5), or Fadd (siFadd), and then exposed to 1 μg/ml Tu for 12 h (a, c, e, and g). As control to test
the functionality of repression, the cells were stimulated with TNF in combination with TAK1 inhibitor (TAK1i) (b), or with anti-Fas antibody (d), or Trail (f and h) in combination with
cycloheximide (CHX) (d, f, and h). The cells were then lysed and immunoblotted as indicated. (i)Ripk1+/+MEFswere transfected as before, stimulated with 1 μg/ml Tunicamycin, and
then the percentage of cell death wasmeasured in function of time using the Fluostar Omega fluorescence plate reader. Error bars represent S.E.M. of three independent experiments
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These results argue against the involvement of the classical
death receptors TNFR1, FAS, and DR5 in tunicamycin-
induced apoptosis, and suggest that caspase-8 activation is
triggered by another pathway.
RIPK1 interacts with IRE1. IRE1 can promote both survival
and death pathways under ER stress conditions,2,3 suggest-
ing that the pro-apoptotic function of RIPK1 could be initiated
by an interaction with IRE1. First, to confirm the pro-apoptotic
role of IRE1 during ER stress, we analyzed cell death and
processing of caspase-8 and -3 in response to tunicamycin in
Ire1− /− cells reconstituted with an empty vector or with a
vector coding for hIRE1.50 As shown in Figures 6a and b, cell
death induction as well as cleavage of caspase-8 and -3 were
more pronounced in the IRE1-reconstituted cells, supporting
a role for IRE1 in signaling toward apoptosis in response to
tunicamycin treatment. A previous report suggests that IRE1
forms a complex with TNFR1 and RIPK1 for regulating JNK
activation in response to ER stress.23 Although our results
indicate that RIPK1 is not crucial for JNK activation, we still
examined the interaction of RIPK1 with IRE1. To do so, we
performed co-immunoprecipitation experiments in lysates of
HEK293T cells ectopically expressing IRE1, RIPK1, and
TNFR1. Interestingly, we confirmed interaction between
RIPK1 and IRE1 when immunoprecipitating either IRE1 or
RIPK1 (Figures 6c and d). However, no interaction between
IRE1 and TNFR1 was detected when immunoprecipitating
IRE1 (Figure 6d). Hence, our results confirm the previously
reported interaction between IRE1 and RIPK1, and suggest
that this interaction, which occurs independently of TNFR1,
could contribute to the pro-apoptotic role of RIPK1 and
IRE1. Accordingly, we observed that the knockdown of Ire1
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Figure 6 RIPK1 interacts with the pro-apoptotic receptor IRE1. (a and b) Ire1−/− cells reconstituted with an empty vector (EV) or with a vector coding for hIRE1(hIRE1) were
stimulated with 1 μg/ml tunicamycin (Tu), and the percentage of cell death was measured in function of time using the Fluostar Omega fluorescence plate reader (a), or cell lysates
obtained after 17 h of stimulation were immunoblotted as indicated (b). (c) HEK293T cells were transiently transfected with plasmids coding for EGFP-hIRE1 and/or Flag-hRIPK1,
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decreased tunicamycin-induced caspases processing in
Ripk1+/+ MEFs while it did not further protect MEFs already
deficient for Ripk1 (Figure 6e).
Discussion
So far, how the UPR switches from a pro-survival to a pro-
death mode, as well as how it proceeds to the execution
phase, are still incompletely understood. On the basis a
previous report suggesting the requirement of RIPK1 for JNK
activation by IRE1,23 we investigated the role of RIPK1 in ER
stress-mediated death. Our data identified RIPK1 as a new
mediator of ER stress-induced apoptosis that regulates the
activation of caspase-8.
It is widely accepted that the UPR triggers the intrinsic
pathway of apoptosis by regulating the expression and
activation of Bcl-2 family members.2,3,7 However, some recent
reports support the idea that ER stress can also trigger
activation of the extrinsic apoptotic pathway through autocrine
production of TNF via IRE1-mediated activation of NF-κB,24 or
through the upregulation of the TRAIL receptor DR5 by the
PERK-CHOP pathway.49,51–54 In addition, ligand-independent
signaling downstream of TNFR1 and DR5 has also been
reported to trigger ER stress-mediated death.23,49,51 Accord-
ingly, caspase-8 activation has been observed under ER
stress conditions.55–57 Our results show that caspase-8 has a
primarily role in ER stress-mediated apoptosis. These data
therefore strongly suggest that activation of caspase-8
represents an early event under ER stress conditions, and
that activation of the intrinsic mitochondrial pathway is a
secondary event relying, for instance, on the cleavage of Bid
by caspase-8.58 Although caspase-2 has previously been
reported to mediate Bid cleavage during ER stress-mediated
death,15,16,59 we did not detect any caspase-2 processing in
our cellular model, which goes in line with a recent report
questioning the requirement of caspase-2 for ER stress-
induced death.60 Importantly, our results also demonstrate
that caspase-8 activation in MEFs does not result from
activation of the extrinsic pathway downstream of TNFR1,
Fas, or DR5, highlighting the potential cell-specific character-
istic of cell death signaling under unresolved ER stress
conditions.
In agreement, we did not detect the formation of a complex
containing RIPK1 and caspase-8, a prerequisite for RIPK1-
dependent apoptosis downstream of TNFR1.29,33,35,61 More-
over, cIAP1/2 depletion had no effect on ER stress-mediated
death in our cellular model whereas they have a crucial role in
TNFR-mediated cell death.28,29,34,35 A BAP31-containing
complex has been reported to function as a caspase-8-
activating platform transducing apoptotic signals from the ER
to the mitochondria under ER stress.62,63 However, our
preliminary results indicate that Bap31 repression in MEFs
did not prevent tunicamycin-induced caspase-8 activation
(data not shown). Further investigations are therefore required
to fully understand the mode of activation of caspase-8 in
response to ER stress and the involvement of RIPK1 in this
process.
Several studies have previously reported a pro-apoptotic
role of IRE1 under prolonged ER stress conditions.11,16,17,20,24
Our results using the Ire1−/−-reconstituted cells, and Ire1
knockdown experiments, confirm a pro-apoptotic function of
IRE1. However, it is important to note that Ire1 deficiency only
slightly protected the cells from tunicamycin-induced caspase
activation in our cellular model. This can potentially be
explained by the dual function of IRE1 that can mediate death
but also survival pathways.2,3 To favor protection from death,
the death signaling branches emerging from IRE1 should be
specifically targeted. For instance, we found that JNK
inhibition provides a better protection toward caspase activa-
tion than Ire1 depletion. Similarly, we observed that Ripk1
depletion protects the cells from tunicamycin-induced apop-
tosis much more potently than Ire1 depletion. One possible
interpretation is that Ripk1 depletion specifically affects the
main killing branch emerging from IRE1. In line with this, we
confirmed an interaction between IRE1 and RIPK1,23 indicat-
ing that RIPK1 can transmit signals initiated at the receptor.
However, in contrast to the report of Yang et al.,23 our results
indicate that RIPK1 is not essential for JNK activation, as
measured by c-Jun phosphorylation. Although unlikely, we
can at this stage not formally exclude an eventual difference in
the transcriptional activity of AP1 between WT and Ripk1-
deficient cells (a similar remark can also be made for CHOP).
We also ruled out the possibility that RIPK1 regulates the
survival function of IRE1 that depends on XBP-1 mRNA
splicing. Since IRE1 recruits numerous proteins to its cytosolic
domain to form a signaling molecular platform referred as the
UPRosome,64 it is tempting to speculate that the binding of
RIPK1 to IRE1 could modulate the kinetic and the amplitude of
IRE1 response to ER stress by regulating the assembling and/
or the composition of the UPRosome. Indeed, alteration of
IRE1 signaling termination leads to excessive RIDD activity,
which is proposed to favor cell death versus survival during
prolonged ER stress.11–14,16 Further work is required to clearly
characterize the consequences of the interaction between
RIPK1 and IRE1. Indeed, we cannot exclude the possibility
that the role of RIPK1 in caspase-8-mediated death goes
beyond its interaction with IRE1.
In conclusion, our findings uncover a novel pro-apoptotic
function of RIPK1 in conditions of unresolved ER stress. We
demonstrate that RIPK1 controls death receptor-independent
activation of caspase-8, which is crucial for apoptosis
induction.
Materials and Methods
Cell culture and plasmids. MEFs and HEK293T cells were cultured in high
glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum and L-glutamine (200 mM). Ripk1+/+ and Ripk1−/− MEFs have been
reported previously.33 In brief, they were isolated from E12.5 littermate embryos and
immortalized with SV40 large T antigen. Reconstitution of the Ripk1−/− MEFs was
done by lentiviral transduction. Viral particles were produced by transfecting
HEK293T cells using calcium phosphate with a pLenti6-puro-HA-Ripk1 or pLenti6-
puro-HA-Luciferase as a control together with the lentiviral packaging vectors
pMD2-VSVG and pCMV-ΔR8.9.1. The medium was changed after 6 h, and the
virus-containing supernatant was collected after 24 and 48 h and used to infect the
Ripk1−/− cells. Infected MEFs were then selected for 3 days by adding 2.5 μg/ml
puromycin to the medium. Ire1− /− cells transduced with an empty pBabe vector or
with a pBabe vector encoding FLAG- hIRE1 were kindly provided by David Ron
(University of Cambridge, UK).50 These cells were cultured in DMEM supplemented
with 10% fetal calf serum, L-glutamine, non-essential amino acids, and puromycin
(3 μg/ml). The EGFP-hIRE1 construct was a kind gift of Sarah Gerlo (University of
Ghent). The Flag-hIRE1 plasmid has previously been reported,65 and the Flag-
RIPK1 construct is a kind gift from Z Chen (University of Texas Southwestern).
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Reagents and antibodies. Tunicamycin was obtained from Sigma-Aldrich
(St. Louis, MO, USA; #T7765) and used at 1 μg/ml. Necrostatin-1 (Calbiochem,
Merck KGaA, Darmstadt, Germany; #480065) was used at 10 μM. Z-VAD-fmk
(Bachem, Bubendorf, Switzerland; #N-1510) was used at 20 μM. Doxycycline
(Sigma-Aldrich #D9891) was used at 1 μg/ml. SP600125 JNK inhibitor (Calbiochem
#420119) was used at 10 and 20 μM. TAK1 kinase inhibitor (AnalytiCon Discovery
GmbH, Potsdam, Germany; #NP-0009245) was used at 1 μM. Recombinant human
TNF was produced in our laboratory, purified to at least 99% homogeneity, had a
specific biological activity of 3–107 IU/mg, and was used at 600 IU/ml (20 ng/ml).
Cycloheximide was from Sigma-Aldrich (#C7698). TRAIL (SuperKiller) was from
Enzo Life Sciences (Farmingdale, NY, USA; #ALX-201-130-C020) and was used at
100 ng/ml. Recombinant mouse Fas:Fc chimera was from R&D Systems (Abingdon,
UK; #435-FA). Antibodies were purchased from the following companies: anti-RIPK1
(BD Biosciences, San Jose, CA, USA; #610459), anti-caspase-8 (Abnova, Jhongli,
Taiwan; #MAB3429), anti-cleaved caspase-8 (Cell Signaling, Danvers, MA, USA;
#9429), anti-caspase-3 (Cell Signaling #9662), anti-cleaved caspase-3 (Cell
Signaling #9661), anti-β-tubulin (Abcam, Cambridge, UK; #ab6046-200), anti-
cleaved PARP (Asp214) (Cell Signaling #9544S), anti-phospho-c-Jun (Cell Signaling
#2361S), anti-c-Jun (Santa Cruz Biotechnology, Dallas, TX, USA; #sc-1694), anti-
IRE1 (Cell Signaling #3294), anti-CHOP (Cell Signaling #2895S), anti-caspase-9
(Cell Signaling #9508), anti-Fas (BD Biosciences #554254), blocking anti-TRAIL
(eBiosciences, San Diego, CA, USA; #165951), anti-Flag M2 (Sigma-Aldrich
#A2220), anti-IRE1 used for immunoprecipitation (Santa Cruz Biotechnology #sc-
20790), and anti-TNFR1 (clone H5) (Santa Cruz Biotechnology #sc-8436). Blocking
anti-TNF was from Bioceros B.V (Utrecht, The Netherlands; #XT-22).
Analysis of cell death and caspase-3 activity. Cell death and
caspase-3 like activity analysis using the Fluostar Omega fluorescent plate reader
(BMG Labtech GmbH, Ortenberg, Germany) was performed as previously
described.33 Briefly, the cells were seeded in triplicate at 7500 cells/well in a 96-
well plate. The next day the cells were treated with the indicated compounds in the
presence of 5 μM SYTOX Green (SG) (Life Technologies, Carlsbad, CA, USA) and
for some experiments in combination with 20 μM DEVD-AMC (PeptaNova GmbH,
Sandhausen, Germany). SG and AMC fluorescence intensity were measured in
function of time with excitation/emission filters of 485/520 nm and 360/460 nm,
respectively. The percentage of cell death was calculated as (induced SG
fluorescence− background SG fluorescence)/(maximal SG fluorescence− back-
ground SG fluorescence)X100. The maximal SG fluorescence was obtained by full
permeabilization of the cells using 0.05% Triton X-100. Caspase-3like activity was
calculated as (induced AMC fluorescence− background AMC fluorescence).
RT-qPCR. Ripk1+/+ and Ripk1− /− MEFs were incubated with 1 μg/ml
tunicamycin for the indicated times, and total RNA was isolated from cell lysates
by using the RNeasy plus mini kit (Qiagen, Hilden, Germany). CHOP mRNA as well
as the housekeeping gene HPRT were examined by RT-qPCR.
Immunoprecipitation. After overnight transfection in HEK293T, or after
tunicamycin treatment in MEFs, cells were washed with PBS and then lysed in cold
lysis buffer (10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40 and 10% glycerol),
supplemented with EDTA-free protease inhibitor cocktail tablets (Roche Diagnostics,
Basel, Switzerland) and phosphatase inhibitor cocktail tablets (Roche Diagnostics).
Flag-RIPK1 was immunoprecipitated using anti-Flag M2 affinity gel (Sigma-Aldrich).
For endogenous caspase-8 immunoprecipitation, cells were treated with
tunicamycin in the presence of 20 μM Z-VAD, and then caspase-8 was
immunoprecipitated using home-made anti-caspase-8 antibody. Anti-caspase-8,
anti-IRE1, and anti-RIPK1 antibodies were coupled to protein A beads for
immunoprecipitation. All immunoprecipitations were performed overnight at 4 °C.
The beads were then recovered by centrifugation, and immunoprecipitates were
washed three times in cold lysis buffer, and eluted in Laemmli’s buffer.
Immunoprecipitates were then analyzed by immunoblot.
RNA interference. For shRNA-based knockdown, Mission shRNA control or
caspase-8 (TRCN0000012243, Sigma-Aldrich) plKO.1 puro vectors were trans-
fected together with the lentiviral packaging vectors pMD2-VSVG and pCMV-
ΔR8.9.1 using the standard calcium phosphate method. The medium was changed
after 6 h, and the sample was collected 48 h post transfection. The virus-containing
supernatants were then used to infect MEF cells, which were then selected for
4 days by adding 3 μg/ml puromycin to the medium. For RNAi-based knockdown,
synthetic non-silencing (D-001810-01) and SMARTpool mouse Tnfr1 (L-060201-
01), Fas (L-045283-00), Dr5 (L-050949-00), Fadd (L-040488-00), and Ire1
(L-041030-00) siRNA were purchased from Dharmacon (Thermo Fisher Scientific,
Waltham, MA, USA). The cells were seeded in 6-well plate, and 25 nM siRNA was
transfected using DharmaFECT 1 reagent (Dharmacon, Thermo Fisher Scientific)
according to the manufacturer’s recommendations. After 48 h of transfection, the
cells were used for experiments.
Statistics. Statistical analysis were performed by two-way ANOVA and
Bonferroni post-tests. A Po0.01 was considered as significant.
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